Free press releases distribution network?

Agency / Source: Cambridge Healthtech Institute

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Four Insightful Conferences to be Held at CHI's Fifth Annual Immunogenicity Summit 2013 - Technologies and Strategies for Safe and Efficacious Products in the Clinic - ImmunogenicitySummit.com / HealthTech.com
Four Insightful Conferences to be Held at CHI's Fifth Annual Immunogenicity Summit 2013

 

PRZOOM - /newswire/ - Needham, MA, United States, 2013/07/25 - Technologies and Strategies for Safe and Efficacious Products in the Clinic - ImmunogenicitySummit.com / HealthTech.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cambridge Healthtech Institute (CHI) announced the final agenda for its Fifth Annual Immunogenicity Summit 2013 to be held on November 11-13, 2013 at the Hyatt Regency on Capitol Hill in Washington, DC.

This year, CHI expanded the scope of the summit to include four concurrent conferences on developing biological drugs with greater safety and efficacy profiles, reduced immunogenicity and a clear regulatory pathway:

Immunogenicity Assessment & Strategies (November 11-12)

Conference Highlights:
• Keynote Presentation: "FDA Perspectives on Issues Regarding Immunogenicity for Monoclonal Antibodies," featuring Kathleen Clouse, Ph.D., FDA/CDER
• Pfizer Case Studies: "Assessment of Neutralizing and Cross-Reacting Antibodies," featuring Jim McNally, Ph.D., Pfizer, and "Immune Complexes without Anti-Drug Antibodies," featuring Deborah Finco, Ph.D., Pfizer
• Teva Pharmaceuticals Case Study: V-5010 and Efforts to Modify COPAXONE®: Immunogenicity Impact on Safety and Regulatory Considerations for Complex Drugs
• Problem Solving Roundtable Discussions: "Managing the Complexities for Innovators and Biosimilars," featuring Kathleen Clouse, Ph.D., Steven J. Swanson, Amgen, Inc.; Jim McNally, Pfizer, Inc.; Kyra J. Cowen, Ph.D., Genentech; Martin Schwickart, Ph.D., MedImmune, Inc.

PK/PD of Novel Constructs (November 11-12)

Conference Highlights:
• Keynote Presentation: "Impact of Brentuximab Vedotin in the Treatment of Lymphoma" featuring Ranjana Advani, M.D., Stanford Cancer Institute
• Trends in Novel Constructs: "Quality Attributes That May Impact PK or Mechanism of Action," featuring Marjorie A. Shapiro, Ph.D., FDA/CDER
• Nonclinical PK/PD of Multi-Specific Modalities Session: "Testing Strategies for the Assessment of Bispecific T cell-engaging BiTE® Antibodies and Their Transition into the Clinic," featuring Benno Rattel, AMGEN Research (Munich) GmbH
• Use of Mechanistic PK/PD Modeling Session: Featuring Tamara Van Steeg, Ph.D., LAP&P Consultants BV; Guozheng Liu, Ph.D., University of Massachusetts Medical Center; Nahor Haddish-Berhane, Ph.D., Pfizer; and Rakesh Sindhi, M.D., Children's Hospital of Pittsburgh

Immunogenicity Risk Assessment & Mitigation (November 12-13)

Conference Highlights:
• Keynote Presentation: "Novel Approach to B and T Epitope Removal from Immunotoxins with Retention of High Cytotoxic Activity," featuring Ira Pastan, M.D., National Institutes of Health
• Panel Discussion: "Relevance of Animal Models for Predicting the Immunogenicity of Therapeutic Proteins," featuring Jack Ragheb, Ph.D., FDA/CDER
• Risk Considerations for Biotherapeutics Session: Featuring Steven J. Swanson, Ph.D, Amgen; Harald Kropshofer, Ph.D., F. Hoffmann-La Roche Ltd.; and Sally Fischer, Ph.D., Genentech
• Problem Solving Roundtable Discussions: "Measures to Reduce Immunogenicity," featuring Steven J. Swanson, Ph.D., Amgen; Harald Kropshofer, Ph.D., F. Hoffmann-La Roche Ltd.; Jack Ragheb, Ph.D., FDA/CDER; and Ira Pastan, M.D., National Institutes of Health

Optimizing Bioassays for Biologics (November 12-13)

Conference Highlights:
• Keynote Presentation: "New Technologies and Approaches to Bioassays," featuring Max L. Tejada, Ph.D., Genentech
• Challenges and Solutions for Optimizing Bioassays Session: Featuring Barbara Hebeis, Ph.D., NDA Analytics; and Surendran Rajendran, Ph.D., Bristol-Myers Squibb
• Dinner Short Course: "Developing Potency Assays to Ensure Successful Biologics," featuring Timothy Schofield, MedImmune
• Problem Solving Roundtable Discussions: "Bioassay Automation Technology," featuring Alexis Rossignol, Ph.D., Clean Cells SAS; Tina S. Morris, Ph.D., United States Pharmacopeial Convention, Global Science & Standards Division; and Brad Greenfield, Theraclone Sciences

"This greatly expanded Immunogenicity Summit is designed to enable the industry to avoid delays and unnecessary expense, and to produce safe and efficacious products for the clinic and beyond," says Nicole Lyscom, Ph.D., Conference Director & Project Team Lead. "This multi-track event is guaranteed to provide attendees with many valuable take home messages from an experienced faculty. Last year, 300 delegates attended and this year's summit is on track to continue growing."

For more details and to register, visit ImmunogenicitySummit.com/.

Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi, lscimemi[.]healthtech.com.

Past Delegate Testimonials:

"You have succeeded in attracting the very best speaker panel I have ever seen to a meeting of this nature." - Advisor, NDA Advisory Board

"Congratulations on a very well put together conference." - Assistant Vice President, Pfizer

"I'm glad I attended the PK/PD meeting. Nowhere else could I find a conference entirely devoted to the in vivo activity of novel constructs." - Principal Scientist, Amgen

"Program and participants, first class." - Associate Director, Novo Nordisk

"Break-out interaction with FDA experts was very valuable." - Associate Director, Alexion Pharmaceuticals Inc.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (chicorporate.com), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Cambridge Healthtech Institute

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Four Insightful Conferences to be Held at CHI's Fifth Annual Immunogenicity Summit 2013

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: James Prudhomme - HealthTech.com 
781-972-5400 jprudhomme[.]healthtech.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cambridge Healthtech Institute securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Cambridge Healthtech Institute / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today